Leading global drugmakers such as MSD Pharmaceuticals, Novartis, AstraZeneca, and Pfizer stand to benefit as it opens new opportunities to expand access to their medicines through PAPs.

Pharma stocks had a mixed response after Finance Minister Nirmala Sitharaman announced customs duty exemptions for 36 essential drugs and reduced rates for six others.

Zydus Takeda Healthcare Private Limited (ZTHPL), a joint venture company set up by Zydus Lifesciences Limited and Takeda ...

In a significant shift in the global pharmaceutical landscape, a substantial portion of French medicines is now being ...

London – M42, a global health leader powered by artificial intelligence (AI), and Hikma Pharmaceuticals PLC (Hikma), ...

Finance Minister Sitharaman announced the inclusion of six life-saving drugs in the concessional 5% duty slab to enhance ...

Indian stock market indices, Sensex and Nifty 50, ended flat amid high volatility today, 1 February 2025, after the Union ...

Finance Minister Nirmala Sitharaman is presenting the 8th consecutive budget in the Parliament, outlining fiscal policies and expenditure proposals. T ...

Trump said flatly this week he’d proceed, and said Friday there was nothing the countries could do to stop him.

In Trump’s view, the 25% tariffs against the two North American allies and a 10% tax on imports from Washington’s chief ...

The White House said Trump's tariff order also includes a mechanism to escalate the rates if the countries retaliate against ...